Company profile
UK company 05732681, incorporated on 7 March 2006.
VivoSight Word leading medical imaging technology
Measure Morphologic and Angiographic Changes Visualize Skin Morphology to a Depth of > 1mm VivoSight DX visualise and quantify treatment effects for: Immune
Company number 05732681
Updated 07 Jul 2026 09:49
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
1 Jul 2012 to 30 Jun 2013
Michelson Diagnostics is an independent UK start-up which has launched the world's first CEmarked, FDA-cleared OCT scanner for diagnosis & monitoring of non-melanoma skin cancer and other skin conditions. Our 'VivoSight' scanner is already being used in a small number of dermatology clinics in USA and Germany on a commercial basis and has the support of l...
1 Dec 2007 to 30 Nov 2009
Awaiting Public Summary
